To evaluate whether the proteasome and/or lysosome pathways are involved in the downregulation of ATGL protein levels in hepatic steatosis, we treated cultured hepatocytes with the proteasome-specific inhibitor MG132 and the lysosomal inhibitor ammonium chloride (NH4Cl), respectively. This evidence concerns the gene PNPLA2 and Hepatic steatosis.